Document is current
Any future updates will be listed below
-
Authors
Zheng, Siqi
Raz, Linoy
Zhou, Lin
Cohen-Sharir, Yael
Tian, Ruifang https://orcid.org/0000-0002-3333-1944
Ippolito, Marica Rosaria
Gianotti, Sara https://orcid.org/0009-0002-7503-7601
Saad, Ron
Wardenaar, Rene https://orcid.org/0000-0001-9891-1897
Broekhuis, Mathilde
Suarez Peredo Rodriguez, Maria
Wobben, Soraya https://orcid.org/0000-0001-7859-9250
van den Brink, Anouk https://orcid.org/0000-0003-1316-8673
Bakker, Petra
Santaguida, Stefano https://orcid.org/0000-0002-1501-6190
Foijer, Floris https://orcid.org/0000-0003-0989-3127
Ben-David, Uri https://orcid.org/0000-0003-0917-6646
-
Funding
Funding for this research was provided by:
EC | ERC | HORIZON EUROPE European Research Council (945674)
U.S. Department of Defense (CA191148)
Israel Science Foundation (1805/21)
Israel Cancer Association (20230018)
Dutch Cancer Society (2015-RUG-7822)
Dutch Cancer Society (2022-4EXPL-14805)
Italian Association for Cancer Research (AIRC-MFAG 2018 - ID. 21665; Bridge Grant 2023 - ID. 29228)
Ricerca Finalizzata (GR-2018-12367077)
Chinese Scholar Council
Israel Cancer Research
Azrieli Foundation Faculty Fellowship
BSF Project Grant (2019228)
Fondazione Cariplo
MIUR | Rita-Levi Montalcini program
Italian Ministry of Health with Ricerca Corrente and 5x1000 funds
AIRC Fellowship (26738-2021)
- License Information
-
More Information
Article History
Received: 4 October 2024
Revised: 13 November 2024
Accepted: 2 December 2024
First Online: 21 January 2025
Change Date: 3 February 2025
Change Type: Update
Change Details: The synopsis text has been corrected after an error was detected.
Disclosure and competing interests statement
: UB-D is a consultant for Accent Therapeutics. FF is the scientific director (Chief Scientific Officer) for iPsomics, which is unrelated to this work. The remaining authors declare no competing interests.
